Skip to main content
Log in

Pregnancy and tyrosinaemia type II

  • Published:
Journal of Inherited Metabolic Disease

Abstract

A female patient with tyrosinaemia type II is reported having undergone two untreated pregnancies. During pregnancies, plasma tyrosine was raised. The outcomes of both offspring show that maternal tyrosinaemia may have an adverse effect on the developing fetus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  • Fois A, Borgogni P, Cioni M, et al (1986) Presentation of the data of the Italian Registry of Oculocutaneous Tyrosinaemia. J Inherit Metab Dis 9(supplement 2): 262-264.

    Google Scholar 

  • Francis DEM, Kirby DM, Thompson GN (1992) Maternal tyrosinaemia II: management and successful outcome. Eur J Pediatr 151: 196-199.

    Google Scholar 

  • Garibaldi LR, Siliato F, de Martini I, et al (1977) Oculocutaneous tyrosinosis: report of two cases in the same family. Helv Paediatr Acta 32: 173-180.

    Google Scholar 

  • Hyanek J, Homolka J, Trnka J, et al (1979) Results of screening for phenylalanine and other amino acid disturbances among pregnant women. J Inherit Metab Dis 2: 59-63.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cerone, R., Fantasia, A.R., Castellano, E. et al. Pregnancy and tyrosinaemia type II. J Inherit Metab Dis 25, 317–318 (2002). https://doi.org/10.1023/A:1016558510123

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016558510123

Keywords

Navigation